Achillion Pharmaceuticals Inc

Address: 
Achillion Pharmaceuticals Inc
300 George Street
06511 New Haven , Connecticut
United States
Phone: 203-624-7000
Connecticut US
Registration country: 
United States
ISIC Code: 
7210
CIK: 
0001070336
Company type: 
Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease.
Overview: 
Achillion is an innovative biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The company is developing three clinical candidates for the treatment of chronic hepatitis C infection. ACH-1625 is a proprietary potent once-daily NS3 protease inhibitor that is currently in Phase II clinical development. ACH-2684 is a highly potent pan-genotypic inhibitor of HCV NS3 protease with pico-molar potency that is currently in Phase 1 clinical development. ACH-2928 and ACH-3102 are potent inhibitors of HCV NS5A that demonstrate pan-genotypic activity.